Leidos Secures $51M Contract for CDC's National Healthcare Safety Network Modernization

Leidos (NYSE: LDOS), a leading Fortune 500 innovation company, has been awarded a significant contract by the Centers for Disease Control and Prevention (CDC) for the modernization of the National Healthcare Safety Network (NHSN). The contract, valued at $51 million over a five-year period, will enable Leidos to leverage its expertise in data management and mission software to enhance patient safety and healthcare delivery across the United States.

The NHSN serves nearly all U.S. hospitals, nursing homes, dialysis facilities, and ambulatory surgery centers, making it a critical cornerstone in enhancing patient safety and healthcare delivery. Leidos' collaboration with the CDC since 2003 has empowered over 160,000 users at more than 38,000 facilities with reliable and actionable data. The company's global workforce of 48,000 collaborates to create smarter technology solutions for customers in heavily regulated industries, ensuring the secure transmission of healthcare data across evolving sites of care.

Leidos will work to advance and modernize the NHSN application, facilitating electronic messaging directly from electronic health records, informing rapid, tailored infection prevention, and allowing decision-makers to monitor healthcare system capacity. Additionally, the platform will track vaccination uptake in healthcare settings, monitor blood safety errors, and help prevent the spread of emerging and enduring threats, such as COVID-19, healthcare-associated infections, and antimicrobial-resistant infections.

The $51 million contract contributes to Leidos' annual revenue growth, with the company reporting approximately $15.4 billion in revenues for the fiscal year ended December 29, 2023. This contract aligns with Leidos' growth strategy, demonstrating the company's commitment to investing in heavily regulated industries and addressing the world's most vexing challenges in national security and health.

In conclusion, Leidos' expertise in data management and mission software, combined with its track record in collaborating with the CDC, positions the company well to successfully execute the NHSN modernization project. The contract's value and duration contribute to Leidos' financial stability and long-term growth prospects, while the project's significance highlights the company's commitment to enhancing patient safety and healthcare delivery in the United States.